| 28 April 2017 | Adjusting for unmeasured confounding in non-randomised longitudinal studies: a methodological review
| Streeter, AJ; Lin, NX; Crathorne, L; et al. |
| 1 November 2017 | Approaches to modelling the cost-effectiveness of interventions for heart failure: a systematic review
| Sadler, S; Watson, L; Crathorne, L; et al. |
| 1 July 2017 | The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
| Huxley, N; Crathorne, L; Varley-Campbell, J; et al. |
| 19 January 2018 | Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children
| Wyatt, KM; Lloyd, J; Creanor, S; et al. |
| 19 January 2018 | Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children
| Wyatt, KM; Lloyd, J; Creanor, S; et al. |
| 19 January 2018 | Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children
| Wyatt, KM; Lloyd JJ; Creanor, S; et al. |
| 6 July 2023 | Early access schemes for innovative health technologies: the views of international stakeholders
| Farmer, C; O'Toole, B; Barnish, MS; et al. |
| 1 March 2018 | Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England.
| Tikhonova, IA; Huxley, N; Snowsill, T; et al. |
| 27 July 2023 | An evaluation of managed access agreements in England based on stakeholder experience
| Farmer, C; Barnish, MS; Trigg, LA; et al. |
| 1 October 2016 | First do no harm: pain relief for the peripheral venous cannulation of adults, a systematic review and network meta-analysis.
| Bond, M; Crathorne, L; Peters, J; et al. |
| 1 June 2017 | Immunosuppressive agents in adult kidney transplantation in the NHS: a model-based economic evaluation
| Snowsill, TM; Moore, J; Mujica Mota, R; et al. |
| 1 August 2016 | Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
| Jones-Hughes, T; Snowsill, T; Haasova, M; et al. |
| 1 August 2016 | Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
| Haasova, M; Snowsill, T; Jones-Hughes, T; et al. |
| 5 October 2022 | Ozanimod for treating moderately to severely active ulcerative colitis [ID3841] A Single Technology Appraisal
| Brand, A; O'Toole, B; Muthukumar, M; et al. |
